|1.||Ross, Robert S: 4 articles (04/2013 - 09/2004)|
|2.||Kodera, Yoshio: 2 articles (10/2015 - 08/2008)|
|3.||Nomura, Fumio: 2 articles (10/2015 - 08/2008)|
|4.||Rangarajan, Erumbi S: 2 articles (05/2015 - 10/2012)|
|5.||Izard, Tina: 2 articles (05/2015 - 10/2012)|
|6.||Marsh, Emily: 2 articles (05/2015 - 01/2015)|
|7.||Morales, Walter: 2 articles (05/2015 - 01/2015)|
|8.||Chua, Kathleen S: 2 articles (05/2015 - 01/2015)|
|9.||Chang, Christopher: 2 articles (05/2015 - 01/2015)|
|10.||Marsh, Zachary: 2 articles (05/2015 - 01/2015)|
11/01/1996 - "In addition, we eliminated the expression of vinculin in embryonal stem (ES) cells and in the embryonal carcinoma F9 line by gene disruption employing homologous recombination. "
04/01/2000 - "Vinculin's role was recently questioned by Goldberg [1997: Cell Motil Cytoskeleton 37:44-53] who observed Shigella motility in mouse embryonal carcinoma 5.51 cells, a genetically modified cell line that reputedly lacked vinculin. "
09/26/1995 - "To test the role of vinculin in cell adhesion and motility, we used homologous recombination to generate F9 embryonal carcinoma and embryonic stem cell clones homozygous for a disrupted vinculin gene. "
03/01/1983 - "Immunofluorescence and immunoblotting techniques were used to study the presence and distribution of vimentin and keratin type intermediate filaments, actin, and vinculin (130 kD protein) during retinoic acid (RA)-induced differentiation of F9 embryonal carcinoma (EC) cells. "
10/01/2004 - "A significant reduction in the levels of vinculin expression was observed at all times of infection. "
05/01/2015 - "Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model."
01/01/2014 - "To examine the effect of EHEC infection on cell mechanics, we carried out a series of experiments to examine HeLa cells with and without EHEC infection to quantify the changes in (1) focal adhesion area, visualized by anti-vinculin staining; (2) the distribution and orientation of stress fibers; and (3) the intracellular viscoelasticity, via directional video particle tracking microrheology. "
01/01/2014 - "Finally, vinculin and Rab5 knockdown reduced infection of S. "
07/29/2011 - "Transient overexpression of either talin-1 or vinculin reduced the susceptibility of human cells to infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) and Moloney murine leukemia virus. "
07/01/2004 - "(3) In actively growing V (AV), alpha-SM actin, calponin and vinculin were 3-, 3.3- and 2.9-fold lower, respectively, in the neointima as compared to the media. "
11/01/1998 - "The most obvious difference with normal vessels is the reiteration of an embryonal expression pattern in smooth muscle cells of the neointima which includes a significant reduction of desmin and alpha-smooth muscle actin, calponin and vinculin. "
07/01/2004 - "Our findings indicate that induction of Cx37 and reduction of desmin precede the phenotypic changes of SMCs, which are characterized by down-regulation of alpha-SM actin, calponin and vinculin, and the formation of a neointima. "
02/01/1997 - "Immunohistochemical detection of vinculin in human rhabdomyosarcomas."
02/01/1997 - "In order to investigate whether anti-vinculin antibodies are helpful in confirming the commitment of rhabdomyosarcomas to the myogenic pathway, we studied immunohistochemically the expression pattern of vinculin in a series of 7 human rhabdomyosarcomas including those of embryonal, botryoid, and pleomorphic subtypes. "
02/01/1997 - "Our results suggested that the positive identification of rhabdomyosarcoma achieved by using antibodies against vinculin in addition to other known myogenic markers may be particularly useful in the differential diagnosis of anaplastic, poorly differentiated sarcomas."
|5.||Proteins (Proteins, Gene)
|2.||Transplantation (Transplant Recipients)
|4.||Drug Therapy (Chemotherapy)